ketanserin and Ear Neoplasms
ketanserin has been researched along with Ear Neoplasms in 1 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Ear Neoplasms: Tumors or cancer of any part of the hearing and equilibrium system of the body (the EXTERNAL EAR, the MIDDLE EAR, and the INNER EAR).
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Bates, GJ | 1 |
Luscombe, FE | 1 |
Other Studies
1 other study available for ketanserin and Ear Neoplasms
Article | Year |
---|---|
Carcinoid metastasis in the middle ear: anaesthetic and surgical management.
Topics: Carcinoid Tumor; Cyproheptadine; Ear Neoplasms; Ear, Middle; Fenclonine; Humans; Ileal Neoplasms; Ke | 1989 |